.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Chinese Patent Office
AstraZeneca
Farmers Insurance
Fish and Richardson
Deloitte
Express Scripts
McKesson
Merck
Cerilliant

Generated: June 28, 2017

DrugPatentWatch Database Preview

CLISTIN Drug Profile

« Back to Dashboard

What is the patent landscape for Clistin, and what generic Clistin alternatives are available?

Clistin is a drug marketed by Ortho Mcneil Pharm and Mcneil and is included in two NDAs.

The generic ingredient in CLISTIN is carbinoxamine maleate. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the carbinoxamine maleate profile page.

Summary for Tradename: CLISTIN

Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list25
Patent Applications: see list627
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CLISTIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ortho Mcneil Pharm
CLISTIN
carbinoxamine maleate
TABLET;ORAL008915-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Mcneil
CLISTIN
carbinoxamine maleate
ELIXIR;ORAL008955-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Farmers Insurance
Express Scripts
Queensland Health
Baxter
Chubb
Covington
US Army
Daiichi Sankyo
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot